Table 4.
CMR-Based Change in Treatment
| Post-CMR Treatment | All patients (n = 208) | All patients Change in treatment | Primary prevention (n = 115) | Primary prevention Change in treatment | Secondary prevention (n = 93) | Secondary prevention Change in treatment |
|---|---|---|---|---|---|---|
| Coronary Revasc | 10 | 10 (5) | 5 | 5 (4) | 5 | 5 (5) |
| CRT upgrade | 3 | 3 (1) | 2 | 2 (2) | 1 | 1 (1) |
| LVAD | 2 | 1 (0.5) | 2 | 1 (1) | 0 | 0 (0) |
| Medical therapy | 56 | 27 (13) | 32 | 15 (13) | 24 | 12 (13) |
| PVI | 13 | 1 (0.5) | 8 | 1 (1) | 5 | 0 (0) |
| PV angioplasty | 1 | 1 (0.5) | 1 | 1 (1) | 0 | 0 (0) |
| VT ablation | 123 | 0 (0) | 65 | 0 (0) | 58 | 0 (0) |
| Total | 208 | 43 (21) | 115 | 25 (22) | 93 | 18 (19)* |
Values are n (%) for all, primary and secondary prevention groups. Coronary Revasc, coronary revascularization procedure; CRT cardiac resynchronization therapy LVAD left ventricular assist device; PVI pulmonary venous isolation procedure; PV pulmonary vein; VT ventricular tachycardia. * p = 0.673 for the comparison of primary versus secondary prevention